Aspire RX-LP6 Aspiration Catheter
510(k) K131998
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK131998 | Date26 Nov 2013 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- QEZ
- FDA applicant
- Control Medical Technology, LLC
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.5150
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Aspire Rx-LP6 Aspiration Catheter is an embolectomy catheter designed for the removal of fresh, soft emboli and thrombi from vessels within the coronary and peripheral vasculature. The device system consists of a 6F rapid exchange aspiration catheter and a 30ml piston syringe.
This device has received FDA 510(k) clearance under the regulation number 870.5150. It is classified as a Class 2 cardiovascular device.
Other devices from Control Medical Technology
Questions
AI-generated answers, 21 Sep 2026
What is the primary purpose of the Aspire Rx-LP6 Aspiration Catheter?
This device is designed for the removal of fresh, soft emboli and thrombi from vessels located within the coronary and peripheral vasculature.
What components are included in the Aspire Rx-LP6 system?
The system is supplied as a complete kit consisting of a 6F rapid exchange aspiration catheter and a 30ml piston syringe to facilitate the aspiration process.
What is the regulatory status of this device?
The Aspire Rx-LP6 Aspiration Catheter has received FDA 510(k) clearance under regulation number 870.5150 and is classified as a Class 2 cardiovascular device.